TABLE 2.
Assay | Screening assay result | Whole genome sequencing result |
Assay clinical analysis |
|||||
---|---|---|---|---|---|---|---|---|
Reference | Deletion | % Accuracy | % Clinical sensitivity | % Clinical specificity | % PPV | % NPV | ||
SΔ69-70 | Reference | 179 | 0 | 93.60 [90.57, 96.63] | 100.0 [100.0] | 98.35 [96.48, 100.0] | 94.83 [89.13, 100.0] | 100.0 [100.0] |
Deletion | 3 | 55 | ||||||
Inconclusive | 11 | 2 | ||||||
ORF1aΔ3675-3677 | Reference | 104 | 0 | 68.00 [62.22, 73.78] | 100.0 [100.0] | 97.20 [94.03, 100.0] | 95.65 [90.84, 100.0] | 100.0 [100.0] |
Deletion | 3 | 66 | ||||||
Inconclusive | 14 | 63 |
aUpper-bound values cannot exceed 100.0%. This applies to all measurements. 95% confidence interval is represented in brackets.